A-A-51043A
17 March 1989
SUPERSEDING
A-A-0051043
4 October 1985
COMMERCIAL ITEM DESCRIPTION
BRETYLIUM TOSYLATE INJECTION
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics:
Shall be Bretylium Tosylate Injection.
All ingredients shall be of pharmaceutical grade.
Shall contain 50 mg of Bretylium Tosylate per ml of solution within the applicable assay limits of the injection.
Workmanship. The product shall be free from defects which detract from its appearance or impair its serviceability.
Unit.
For Size 1 – Package (PG). Shall be supplied 10 ml in a commercially available ampul. One package containing 20 ampuls, as specified, constitutes one unit.
For Size 2 – Package (PG0. Shall be supplied 10 ml in a commercially available clear, colorless, cylindrical, flat, bottom, graduated, threaded, rubber stoppered glass vial with plastic plug cup. Each vial shall be packaged together with a translucent, plastic vial injector containing a plastic cylinder, threaded at one end and attached to the base of the injector barrel at the other, and a 21-22 gage x 1 ˝ inch needle (exposed) extending the length of and projecting from the barrel. The injector shall be sealed with a plastic needle guard and a plastic snap cap. The fluid pathway of all components shall be sterile. One package containing 10 syringe-needle units, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business